Bentham Science Logo

Track Your Manuscript:


Current Cancer Drug Targets

Volume 21, 11 Issues, 2021
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access

Contents

Current Cancer Drug Targets, Volume 14 - Number 2


The Role of E-Cadherin Down-Regulation in Oral Cancer: CDH1 Gene Expression and Epigenetic Blockage

, 14(2): 115 - 127

G. Pannone, A. Santoro, A. Feola, P. Bufo, P. Papagerakis, L. Lo Muzio, S. Staibano, F. Ionna, F. Longo, R. Franco, G. Aquino, M. Contaldo, S. De Maria, R. Serpico, A. De Rosa, C. Rubini, S. Papagerakis, A. Giovane, V. Tombolini, A. Giordano, M. Caraglia and M. Di Domenico


DOI: 10.2174/1568009613666131126115012





Cationic Liposome Mediated Delivery of FUS1 and hIL-12 Coexpression Plasmid Demonstrates Enhanced Activity against Human Lung Cancer

, 14(2): 167 - 180

Jiang Ren, Chuanjiang Yu, Shifei Wu, Feng Peng, Qianqian Jiang, Xuechao Zhang, Guoxing Zhong, Huashan Shi, Xiang Chen, Xiaolan Su, Xinmei Luo, Wen Zhu and Yuquan Wei


DOI: 10.2174/1568009614666140113115651






Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.

Advertisement

Sep-2021-ban

Related Journals

Related eBooks

eBooks Catalog